Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-26-061765
Filing Date
2026-05-28
Accepted
2026-05-28 08:05:18
Documents
3
Period of Report
2026-05-28

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0292428-6k_enlivex.htm 6-K 9189
2 PRESS RELEASE ea029242801ex99-1.htm EX-99.1 14168
3 GRAPHIC ea029242801_ex99-1img1.jpg GRAPHIC 7377
  Complete submission text file 0001213900-26-061765.txt   35115
Mailing Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV Israel
Business Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV Israel 972 (0) 3 7326616
Enlivex Ltd. (Filer) CIK: 0001596812 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36578 | Film No.: 261028609
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)